Lindenhofgruppe

What Lindenhofgruppe does

Lindenhofgruppe AG is a privately held Swiss hospital group headquartered in Bern, operating three acute-care facilities — Lindenhofspital (284 beds, 13 operating theaters; founded 1908), Sonnenhofspital (104 beds, 4 theaters; founded 1957), and Engeriedspital (73 beds, 4 theaters; founded 1907) — for a combined footprint of 461 beds and 21 operating theaters. The group delivers inpatient and outpatient care across 50-plus medical specialties, anchored by tertiary oncology (with DKG-certified Gynecological Oncology, Hemato-Oncology, and Bladder Cancer Transit centers), IVHSM-authorized visceral surgery (complex bariatric and deep rectal procedures) and urology (cystectomy), orthopedics and trauma at Sonnenhofspital, gynecology/obstetrics at Engeriedspital, and 24/7 emergency services across two emergency centers plus a walk-in City Notfall clinic. Advanced technology infrastructure includes the Da Vinci robotic-assisted surgical system, EOS low-dose 3D imaging, a clinical information system for medication and patient records, and ERAS (Enhanced Recovery After Surgery) protocols; a Forschungszentrum research center and Campus SLB support investigator-initiated clinical research, while 12 SIWF-recognized postgraduate training facilities train approximately 70 residents annually.

The group operates as a Listenspital (listed hospital) with private management under the regulated Swiss healthcare system, billing inpatient care via SwissDRG and outpatient services separately, with supplementary charges tied to basic, semi-private, and private insurance tiers. Revenue derives from a diverse mix of insured patients across the Bern metropolitan catchment, with patient acquisition through physician referrals, self-presented emergencies, and direct scheduling into outpatient and day-hospital services; the group reported patient satisfaction of 5.7/6 and an NPS of 81 in 2021 (86% Promoters). On January 14, 2026, Lindenhofgruppe sold a majority stake in its laboratory subsidiary LabPoint Medizinische Laboratorien AG to Affidea Schweiz, retaining a minority shareholding and remaining a key client, refocusing the group on hospital operations. Leadership comprises CEO Guido Speck and CMO Dr. med. Meinrad Lienert, with quality and patient safety functions restructured in 2022 to place Patient Safety under the CMO directorate.

Name

Lindenhofgruppe

Legal name

Lindenhofgruppe AG

Website

https://lindenhofgruppe.ch

Company type

Private

Founded year

1907

Operating status

Operating

Headcount range

251–500 employees

Short description

Lindenhofgruppe AG is a privately held Bern-based hospital group operating three acute-care facilities (461 beds, 21 operating theaters) that deliver inpatient, outpatient, emergency, oncology, orthopedic, and maternity services to residents of the Bern metropolitan area under the Swiss Listenspital framework.

Ownership category

akta.pro rank

Product category

Acute Care Hospital Services

NAICS

General Medical and Surgical Hospitals (622110), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA), After-Hours & Walk-In Primary Care Clinics (HLAFADAH)

Keywords

• Acute care hospital
• Oncology treatment
• Emergency medicine
• Orthopedic surgery
• Maternity services

Headquarters

HQ city

Bern

HQ country

Switzerland

HQ region

Europe

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Hospital Services Revenue: Lindenhofgruppe generates revenue through providing medical services including emergency care, surgical procedures, inpatient care, outpatient treatments, diagnostic services (laboratory, radiology, imaging), and specialized treatments. Services are billed under Swiss DRG (diagnosis-related groups) system for inpatient care, with outpatient services billed separately. The group operates as a listed hospital (Listenspital) with private management, contracted with health insurers for covered services.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Lindenhofgruppe AG operates three acute care hospitals in Bern, Switzerland (Lindenhofspital with 284 beds, Sonnenhofspital with 104 beds, and Engeriedspital with 73 beds), providing comprehensive inpatient and outpatient medical services across more than 35 specialty areas including oncology, orthopedics, cardiology, neurology, gynecology, and 24/7 emergency medicine. Services are billed through the Swiss DRG system with patient costs varying across basic, semi-private, and private insurance tiers.

Product overview

Lindenhofgruppe AG is a Swiss hospital group operating three acute care hospitals (Engeriedspital, Lindenhofspital, Sonnenhofspital) in Bern, Switzerland. The group provides comprehensive inpatient and outpatient medical services across more than 35 specialist departments including oncology, orthopedics, cardiology, neurology, gynecology, and emergency medicine. The hospitals operate specialized centers such as the Hämato-Onkologiezentrum Bern, Onkologiezentrum Bern, Brustzentrum Bern, Prostatazentrum Bern, Darmzentrum Bern, and Gynäko-Onkologiezentrum Bern. Patient-facing digital services include a patient portal for administrative tasks, and the group offers educational events such as the annual Berner Tumortag (Courage – Berner Tumortag) for cancer patients and relatives.

Differentiator

Problem solved

Functional benefit

Brands

• Engeriedspital: Hospital founded in 1907, part of Lindenhofgruppe
• Lindenhofspital
• Sonnenhofspital

Products and services

• Lindenhofspital
• Sonnenhofspital
• Engeriedspital
• Onkologiezentrum Bern
• Hämato-Onkologiezentrum Bern
• Gynäko-Onkologiezentrum Bern
• Brustzentrum Bern
• Notfallzentrum Bern
• Patientenportal
• Baby & Familie
• Forschungszentrum Lindenhofgruppe

Quantifiable outcome

• Patient satisfaction score of 5.7/6 (up from 5.6)
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Affidea SchweizcoreStrategic or Co-development Partner · 14 January 2026Affidea Group, a pan-European specialized healthcare services provider, acquired a majority stake in LabPoint S.A. from Lindenhofgruppe. Lindenhofgruppe retains a minority stake and continues as a key medical partner. The acquisition adds five laboratory locations and approximately 170 professionals to Affidea Switzerland's existing network of 33 imaging and specialist centers.
• Campus SLB (Stiftung Lindenhof Bern)coreStrategic or Co-development PartnerCampus SLB is a non-profit subsidiary of Stiftung Lindenhof Bern that supports researchers at Lindenhofgruppe with clinical trial management, research project support, modern infrastructure, resources, and expertise. All scientifically active disciplines benefit from this research campus.
• Swiss Institute for Medical Continuing Education (SIWF)coreOthersThe group maintains 12 SIWF-recognized training facilities for medical residents in both hospital physician and attending physician disciplines, supporting approximately 70 residents annually across specialties including Internal Medicine, Intensive Care, Gynecology, Surgery, Orthopedics, Oncology, and Ophthalmology.
• Swissnoso (National Center for Infection Prevention)minorOthersLindenhofgruppe participates in national surgical site infection surveillance programs coordinated by Swissnoso, contributing to quality benchmarking against Swiss averages.
• ANQ (National Association for Quality Development)minorOthersParticipation in ANQ quality measurement programs including patient satisfaction surveys, rehospitalization rates, and clinical quality indicators for national benchmarking.
• Krebsliga Bern (Bern Cancer League)minorOthersCollaboration with Krebsliga Bern for patient education events such as the Berner Tumortag, patient support services, and survivorship programs.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Hirslanden: Largest private hospital group in Switzerland, operating ~17 hospitals including tertiary facilities. Direct comparable as a private, multi-site Swiss acute care group competing for similar DRG-funded inpatient volume.
• Swiss Medical Network: Swiss private hospital group operating multiple acute care and specialty clinics across language regions. Comparable as a privately managed, multi-site Swiss hospital network pursuing specialty center strategies.
• Insel Gruppe: University hospital of Bern and the dominant tertiary care provider in the same catchment as Lindenhofgruppe. Direct competitor for complex cases, IVHSM procedures and academic prestige in Bern.

Regional players

• Spital STS AG: Public hospital group operating in the Bern canton/Thun region. Competes with Lindenhofgruppe for surrounding-canton referrals and DRG-funded inpatient volume in adjacent geographies.
• Spitalzentrum Biel: Public acute hospital in nearby Biel/Bienne competing for Bern-region specialty referrals and basic inpatient cases. Relevant peer for catchment overlap in the wider Bern administrative region.
• Schoen Clinic: German private hospital group specialized in orthopedics, neurology and psychosomatic care. Comparable as a specialty-focused private operator pursuing center-of-excellence models in DACH-region acute care.

Broad incumbents

• Universitätsspital Zürich (USZ): Major Swiss university hospital providing tertiary and academic medicine. Comparable as a broad incumbent competing for highly specialized medicine (IVHSM) mandates and complex case mix across Switzerland.
• CHUV / Lausanne University Hospital: Swiss university hospital providing comprehensive acute and academic care. Comparable as a publicly owned broad incumbent competing for DKG-class oncology and IVHSM authorizations at the national level.
• Asklepios Kliniken: Large German private hospital operator with broad acute and specialty care portfolio. Comparable as a multi-site private hospital group facing similar DRG-driven pricing dynamics and specialist staffing challenges.

Others

• Affidea: Pan-European diagnostics and specialty outpatient operator that acquired LabPoint from Lindenhofgruppe in 2026. Adjacent peer / partner now supplying the group's laboratory services and competing in outpatient diagnostics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/lindenhofgruppe
• LinkedInlinkedin.com/company/lindenhofgruppe

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lindenhofgruppe